A Food & Drug Administration panel approved a Boston Scientific Corp. (NYSE:BSX) bid to expand the indication of its cardiac resynchronization therapy defibrillators to cover patients suffering from ...

The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s application to expand the indications for certain pacemakers and defibrillators for patients with heart failure. The ...

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Defibrillators and pacemakers help the heart maintain a regular rhythm. Defibrillators deliver a shock if the heart goes into arrhythmia. Pacemakers use electrical impulses to keep the heart from ...

Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED; rapid ...

There was an interesting article in the January 4, 2011 edition of the Wall Street Journal that brings to light the significant issue of over-implantation (or perhaps under-implantation) of ...